Cited by 142Cardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 238 of the 240 references it cites were found in a registry or an index.

Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)

Open access

Lane, Deirdre A., Aguinaga, Luis, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Dan, Gheorge-Andrei, Hills, Mellanie True, Hylek, Elaine M., LaHaye, Stephen A., Lip, Gregory Y.H., Lobban, Trudie, Mandrola, John, McCabe, Pamela J., Pedersen, Susanne S., Pisters, Ron, Stewart, Simon, Wood, Kathryn, Potpara, Tatjana S., Document Reviewers, Gorenek, Bulent, Conti, Jamie Beth, Keegan, Roberto, Power, Suzannah, Hendriks, Jeroen, Ritter, Philippe, Calkins, Hugh, Violi, Francesco, Hurwitz, Jodie·2015·Europace

DOI 10.1093/europace/euv233

Open this paper in CoChat — free account

Abstract

Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are of-ten highly symptomatic and the psychological impact of the disease can be significant. Patients’ beliefs and knowledge about their health(and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients’ values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy.It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a TaskForce was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS),Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoa-mericana de Estimulacio ́n Cardı ́aca y Electrofisiologı ́a (SOLEACE),with the remit to comprehensively review the published evidenceavailable, to publish a joint consensus document on patient valuesand preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. Hence this unique consensus document focuses on patients, summarizing the available literature on patients’ experiences of living with various cardiac tachyarrhythmias and their treatment preferences,and identifies gaps in knowledge which will help to inform clinical practice and future research. The document will also summarize key points for discussions with patients during consultations regarding their condition, treatment options, disease trajectory, treatment goals, and outcomes. Finally, this document provides links to useful resources and patient advocacy groups and organizations and professional societies relevant to each group of cardiac tachyarrhythmias.

Integrity signals

Registry

Crossref · 10.1093/europace/euv233

Cites

238 of 238 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)
(1999) · The Lancet · doi:10.1016/s0140-6736(99)04440-2 · Cited by 5,141
Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango)
Charles, C., Gafni, A., & Whelan, T. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00221-3 · Cited by 4,137 · cited 1×
“This emphasizes the complex interactions between anxiety and depression and AF, as well as the need for personalized management of AF(53) and shared decision-making.(54) This also applies in cases where AV node ablation with pacemaker implantation is needed to achieve satisfactory”
Background
Mild cognitive impairment
Gauthier, S. G., Reisberg, ‌., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823

Show all 240 references

Research works printed but not linked: 1

Hills MT . Atrial fibrillation: the patient perspective to better care. EP Lab Digest 2011;11:10.

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129
Antithrombotic Therapy for Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R. A., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M. P., Werring, D. J., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.040 · Cited by 963
Screening for Atrial Fibrillation
Freedman, B., Camm, A. J., Calkins, H. G., Healey, J. S., Rosenqvist, M., Wang, J., Albert, C. M., Anderson, C. S., Antoniou, S., Benjamin, E. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026693 · Cited by 559
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 335
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).
Mairesse, G., Moran, P., van Gelder, I. V., Elsner, C., Rosenqvist, M., Mant, J., Banerjee, A., Gorenek, B., Brachmann, J., Varma, N., et al. (2018) · Europace · doi:10.1093/europace/eux177 · Cited by 191
Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial
Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.07.003 · Cited by 241
Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Dan, G., Martínez‐Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaïta, F., Gelder, I. C. V., Görenek, B., Kaski, J. C., Kjeldsen, K. P., et al. (2018) · EP Europace · doi:10.1093/europace/eux373 · Cited by 247
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188
Adherence to oral anticoagulant therapy in patients with atrial fibrillation
Raparelli, V., Proietti, M., Cangemi, R., Lip, G. Y. H., Lane, D. A., & Basili, S. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-10-0757 · Cited by 184
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
Clarkesmith, D., Pattison, H. M., Khaing, P., & Lane, D. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008600.pub3 · Cited by 152
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.057 · Cited by 145
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Kirchhof, P. F., BREITHARDT, G. E., Bax, J. J., Benninger, G., Blomström‐Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H. G., et al. (2015) · EP Europace · doi:10.1093/europace/euv304 · Cited by 143
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 134
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
Savelieva, I., Fumagalli, S., Kenny, R. A., Anker, S. D., Bénétos, A., Boriani, G., Bunch, T. J., Dagres, N., Dubner, S., Fauchier, L., et al. (2022) · EP Europace · doi:10.1093/europace/euac123 · Cited by 137
European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers
Kotecha, D., Chua, W., Fabritz, L., Hendriks, J., Casadei, B., Schotten, U., Vardas, P. E., Heidbüchel, H., Dean, V., & Kirchhof, P. F. (2017) · EP Europace · doi:10.1093/europace/eux299 · Cited by 118
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)
Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H. G., Chin, A., Coats, A. J. S., Deharo, J., Svendsen, J. H., Heidbüchel, H., Isa, R., et al. (2019) · EP Europace · doi:10.1093/europace/euz046 · Cited by 127
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Gorog, D. A., Gue, Y. X., Chao, T., Fauchier, L., Ferreiro, J. L., Huber, K., Konstantinides, S., Lane, D. A., Marín, F. R., Oldgren, J., et al. (2022) · Thrombosis and Haemostasis · doi:10.1055/s-0042-1750385 · Cited by 116
Exercise-based cardiac rehabilitation for adults with atrial fibrillation
Risom, S. S., Zwisler, A., Palm, P., Sibilitz, K. L., Lindschou, J., Gluud, C. N., Taylor, R. S., Svendsen, J. H., & Berg, S. K. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011197.pub2 · Cited by 117
Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association
Walker, D., Gale, C. P., Lip, G. Y. H., Martín‐Sánchez, F. J., McIntyre, H., Mueller, C. E., Price, S., Sanchís, J. M., Vidán, M. T., Wilkinson, C., et al. (2018) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872618758931 · Cited by 107
Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents
Ruff, C. T., Giugliano, R. P., & Antman, E. M. (2016) · Circulation · doi:10.1161/circulationaha.116.021831 · Cited by 109
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire
Desteghe, L., Engelhard, L., Raymaekers, Z., Kluts, K., Vijgen, J. M., Dilling-Boer, D. M., Koopman, P., Schurmans, J., Dendale, P., & Heidbüchel, H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.303 · Cited by 91
Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association
Hernández‐Madrid, A., Potpara, T., Dagres, N., Chen, J., Larsen, T. B., Estner, H., TODD, D. M., Bongiorni, M. G., Sciaraffia, E., Proclemer, A., et al. (2016) · EP Europace · doi:10.1093/europace/euv448 · Cited by 68
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society
Gorog, D. A., Gue, Y. X., Chao, T., Fauchier, L., Ferreiro, J. L., Huber, K., Konstantinides, S., Lane, D. A., Marín, F. R., Oldgren, J., et al. (2022) · EP Europace · doi:10.1093/europace/euac020 · Cited by 70
Patients’ attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association
Amara, W., Larsen, T. B., Sciaraffia, E., Hernández‐Madrid, A., Chen, J., Estner, H., TODD, D. M., Bongiorni, M. G., Potpara, T., Dagres, N., et al. (2015) · EP Europace · doi:10.1093/europace/euv317 · Cited by 63
Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association
Haugaa, K. H., Potpara, T., Bovéda, S., Deharo, J., Chen, J., Dobreanu, D., Fumagalli, S., Lenarczyk, R., Hernández‐Madrid, A., Larsen, T. B., et al. (2017) · EP Europace · doi:10.1093/europace/eux365 · Cited by 58
A systematic review of patient‐reported outcomes associated with the use of direct‐acting oral anticoagulants
Afzal, S. K., Hasan, S. S., & Babar, Z. U. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13985 · Cited by 53
Patient values and preferences for antithrombotic therapy in atrial fibrillation
Loewen, P. S., Ji, T. A., Kapanen, A. I., & McClean, A. R. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-10-0787 · Cited by 53
Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management
Boriani, G., Lee, G., Parrini, I., López‐Fernández, T., Lyon, A. R., Suter, T. M., van der Meer, P., Cardinale, D. M., Lancellotti, P., Zamorano, J. L., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa054 · Cited by 52
Women with PSVT are often misdiagnosed, referred later than men, and have more symptoms after ablation
Carnlöf, C., Iwarzon, M., Jensen‐Urstad, M., Gadler, F., & Insulander, P. (2017) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2017.1385837 · Cited by 51
Health Literacy and Atrial Fibrillation: Relevance and Future Directions for Patient-centred Care
Aronis, K. N., Edgar, B., Lin, W., Martins, M. A. P., Paasche‐Orlow, M. K., & Magnani, J. W. (2017) · European Cardiology Review · doi:10.15420/ecr.2017:2:2 · Cited by 49
Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study
Clarkesmith, D. E., Lip, G. Y. H., & Lane, D. A. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.03.002 · Cited by 46
Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress
Thylén, I., Moser, D. K., Strömberg, A., Dekker, R. L., & Chung, M. L. (2015) · EP Europace · doi:10.1093/europace/euv220 · Cited by 45
Living with an implantable cardioverter defibrillator: patients' preferences and needs for information provision and care options
Pedersen, S. S., Knudsen, C., Dilling, K., Sandgaard, N. C. F., & Johansen, J. B. (2016) · Europace · doi:10.1093/europace/euw109 · Cited by 43
Availability of patient decision aids for stroke prevention in atrial fibrillation: A systematic review
O’Neill, E. S., Grande, S. W., Sherman, A. E., Elwyn, G. J., & Coylewright, M. J. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.05.014 · Cited by 43
Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018) · Clinical Cardiology · doi:10.1002/clc.22971 · Cited by 45
Effectiveness and usability of an online tailored education platform for atrial fibrillation patients undergoing a direct current cardioversion or pulmonary vein isolation
Desteghe, L., Germeys, J., Vijgen, J. M., Koopman, P., Dilling-Boer, D. M., Schurmans, J., Delesie, M., Dendale, P., & Heidbüchel, H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.065 · Cited by 42
Atrial fibrillation prevention: an appraisal of current evidence
Boriani, G., & Proietti, M. (2017) · Heart · doi:10.1136/heartjnl-2017-311546 · Cited by 41
Cardiac Rehabilitation for Patients Treated for Atrial Fibrillation With Ablation Has Long-Term Effects: 12-and 24-Month Follow-up Results From the Randomized CopenHeartRFA Trial
Risom, S. S., Zwisler, A., Sibilitz, K. L., Rasmussen, T. B., Taylor, R. S., Thygesen, L. C., Madsen, T. S., Svendsen, J. H., & Berg, S. K. (2020) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2020.06.026 · Cited by 38
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry
Mazurek, M., Shantsila, E., Lane, D. A., Wolff, A., Proietti, M., & Lip, G. Y. H. (2017) · Stroke · doi:10.1161/strokeaha.116.016146 · Cited by 35
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA)
Pedretti, R. F. E., Iliou, M., Israel, C. W., Abreu, A., Miljoen, H., Corrà, U., Stellbrink, C., Gevaert, A. B., Theuns, D. A. M. J., Piepoli, M. F., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa121 · Cited by 35
Effect of reinforced, targeted in-person education using the Jessa Atrial fibrillation Knowledge Questionnaire in patients with atrial fibrillation: A randomized controlled trial
Desteghe, L., Engelhard, L., Vijgen, J. M., Koopman, P., Dilling-Boer, D. M., Schurmans, J., Delesie, M., Dendale, P., & Heidbüchel, H. (2018) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515118804353 · Cited by 34
Educational interventions to improve outcomes in patients with atrial fibrillation—a systematic review
Palm, P., Qvist, I., Rasmussen, T. B., Christensen, S. W., Håkonsen, S. J., & Risom, S. S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13629 · Cited by 32
Oral Anticoagulation in Atrial Fibrillation: Development and Evaluation of a Mobile Health Application to Support Shared Decision-Making
Stephan, L. S., Almeida, E. D., Guimarães, R. B., Ley, A. G., Mathias, R. G., Assis, M. V., & Leiria, T. L. L. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170181 · Cited by 34
Association of sex and atrial fibrillation therapies with patient-reported outcomes
Gleason, K. T., Himmelfarb, C. D., Ford, D. E., Lehmann, H. P., Samuel, L. J., Jain, S. K., Naccarelli, G. V., Aggarwal, V., & Nazarian, S. (2019) · Heart · doi:10.1136/heartjnl-2019-314881 · Cited by 31
Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial
the AEGEAN Study Investigators, Montalescot, G., Brotons, C., Cosyns, B., Crijns, H. J. G. M., D’Angelo, A., Drouet, L. O., Eberli, F. R., Lane, D. A., Besse, B., et al. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00356-2 · Cited by 34
Patient Education on Oral Anticoagulation
Hawes, E. M. (2018) · Pharmacy · doi:10.3390/pharmacy6020034 · Cited by 32
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: apost hocanalysis of the X-VeRT trial
Hohnloser, S. H., Cappato, R., Ezekowitz, M. D., Evers, T., Şahin, K., Kirchhof, P. F., Meng, I. L., van Eickels, M., & Camm, A. J. (2015) · EP Europace · doi:10.1093/europace/euv294 · Cited by 28
Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists
Konieczyńska, M., Sobieraj, E., Bryk, A. H., Dębski, M., Polak, M., Podolec, P. S., Małecka, B., Pająk, A., Desteghe, L., Heidbüchel, H., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.a2018.0069 · Cited by 27
Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation
Ageno, W., Beyer‐Westendorf, J., & Rubboli, A. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1361405 · Cited by 27
Patients’ Experiences of Living with Atrial Fibrillation: A Mixed Methods Study
Stridsman, M., Strömberg, A., Hendriks, J., & Walfridsson, U. (2019) · Cardiology Research and Practice · doi:10.1155/2019/6590358 · Cited by 26
Empowerment of athletes with cardiac disorders: a new paradigm
Providencia, R. A., Teixeira, C., Segal, O. R., Ullstein, A., Mueser, K. T., & Lambiase, P. D. (2017) · EP Europace · doi:10.1093/europace/eux268 · Cited by 22
Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
Lane, D. A., Meyerhoff, J., Rohner, U., & Lip, G. Y. H. (2018) · TH Open · doi:10.1055/s-0038-1666803 · Cited by 22
Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic
Lee, S. I., Sayers, M., Lip, G. Y. H., & Lane, D. A. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12712 · Cited by 22
Gender and age differences in symptoms and health‐related quality of life in patients with atrial fibrillation referred for catheter ablation
Walfridsson, U., HANSEN, P. S., Charitakis, E., Almroth, H., Jönsson, A., Karlsson, L., Liuba, I., Samo-Ayou, R., Poçi, D., Holmqvist, F., et al. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13795 · Cited by 22
Stroke prevention in atrial fibrillation: State of the art
Li, Y., & Lip, G. Y. H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.057 · Cited by 21
Inflammatory cytokines and cardiac arrhythmias: from pathogenesis to potential therapies
Obeagu, E. I. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003499 · Cited by 20
Patient-Reported Treatment Satisfaction with Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation in China
Geng, Y., Lan, D.-H., Liu, N., Du, X., Zheng, D., Tang, R., Long, D., Yu, R., Sang, C., Bai, R., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1670661 · Cited by 20
A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation
Lip, G. Y. H., Potpara, T., Boriani, G., & Blomström‐Lundqvist, C. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12468 · Cited by 19
Excess of exercise increases the risk of atrial fibrillation
Müssigbrodt, A., Weber, A., Mandrola, J. M., Belle, Y. V., Richter, S., Döring, M., Arya, A., Sommer, P., Bollmann, A., & Hindricks, G. (2017) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12830 · Cited by 19
Evaluating the Effect of a Patient Decision Aid for Atrial Fibrillation Stroke Prevention Therapy
Loewen, P. S., Bansback, N. J., Hicklin, J., Andrade, J. G., Kapanen, A. I., Kwan, L., Lynd, L. D., McClean, A. R., MacGillivray, J., & Salmasi, S. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019828420 · Cited by 19
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor
Potpara, T., Dagres, N., Mujović, N. M., Vasić, D., Ašanin, M., Nedeljkovic, M. A., Marín, F. R., Fauchier, L., Blomström‐Lundqvist, C., & Lip, G. Y. H. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0458-7 · Cited by 16
Symptoms and health‐related quality of life 5 years after catheter ablation of atrial fibrillation
Walfridsson, U., Jönsson, A. H., Karlsson, L., Liuba, I., Almroth, H., Sandgren, E., Walfridsson, H., & Charitakis, E. (2021) · Clinical Cardiology · doi:10.1002/clc.23752 · Cited by 16
Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation
Januszkiewicz, Ł., Barra, S., Marijon, E., Providencia, R., de Asmundis, C., Chun, J. K. R., Farkowski, M. M., Conte, G., & Boveda, S. (2023) · EP Europace · doi:10.1093/europace/euac275 · Cited by 15
Retracted
Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA)
Pedretti, R. F. E., Iliou, M., Israel, C. W., Abreu, A., Miljoen, H., Corrà, U., Stellbrink, C., Gevaert, A. B., Theuns, D. A. M. J., Piepoli, M. F., et al. (2021) · EP Europace · doi:10.1093/europace/euaa427 · Cited by 15
Individualized education focusing on self‐management improved the knowledge and self‐management behaviour of elderly people with atrial fibrillation: A randomized controlled trial
Oh, Y.-H., & Hwang, S. Y. (2021) · International Journal of Nursing Practice · doi:10.1111/ijn.12902 · Cited by 13
Gender and age differences in symptoms and health‐related quality of life in patients with atrial fibrillation referred for catheter ablation
Walfridsson, U., HANSEN, P. S., Charitakis, E., Almroth, H., Jönsson, A., Karlsson, L., Liuba, I., Samo-Ayou, R., Poçi, D., Holmqvist, F., et al. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13818 · Cited by 13
[2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].
Shamloo, A. S., Dagres, N., & Hindricks, G. (2021) · PubMed · doi:10.1007/s00059-020-05005-y · Cited by 11
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy
Rivera‐Caravaca, J. M., Esteve‐Pastor, M. A., Camelo-Castillo, A. J., Ramírez-Macías, I., Lip, G. Y. H., Roldán, V., & Marín, F. R. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1789099 · Cited by 11
Stroke prevention in atrial fibrillation: Closing the gap
Pokorney, S. D., Gersh, B. J., Ahmad, A., Al‐Khatib, S. M., Blank, M. J., Coylewright, M. J., DiBattiste, P. M., Healey, J. S., Hedrich, O., Hylek, E. M., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.10.004 · Cited by 11
The Danish Future Patient Telerehabilitation Program for Patients With Atrial Fibrillation: Design and Pilot Study in Collaboration With Patients and Their Spouses
Dinesen, B., Gade, J. D., Schacksen, C. S., Spindler, H., Albertsen, A. E., Dittmann, L., Jochumsen, M., & Møller, D. S. (2021) · JMIR Cardio · doi:10.2196/27321 · Cited by 10
Implementation of patient education for patients with atrial fibrillation: nationwide cross-sectional survey and one-year follow-up
Qvist, I., Lane, D. A., Risom, S. S., Hendriks, J., Højen, A. A., Johnsen, S. P., & Frost, L. (2023) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvad066 · Cited by 10
Developing a Complex Educational–Behavioural Intervention: The TREAT Intervention for Patients with Atrial Fibrillation
Clarkesmith, D. E., Pattison, H. M., Xuereb, C. B., & Lane, D. A. (2016) · Healthcare · doi:10.3390/healthcare4010010 · Cited by 10
Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT 2 R 2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol
Phrommintikul, A., Nathisuwan, S., Gunaparn, S., Krittayaphong, R., Wongcharoen, W., Sehmi, S., Mehta, S. P., Winkles, N., Brocklehurst, P., Mathers, J. M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051987 · Cited by 10
Knowledge about atrial fibrillation and anticoagulation affects the risk of clinical outcomes
Konieczyńska, M., Bijak, P., Malinowski, K. P., & Undas, A. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.03.011 · Cited by 10
Atrial Fibrillation and Stroke
Proietti, M., & Lip, G. Y. H. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.006 · Cited by 10
Application of Alfalfa App in the management of oral anticoagulation in patients with atrial fibrillation: a multicenter randomized controlled trial
Xu, W., Huang, X., Lin, Q., Wu, T., Guan, C., Lv, M., Hu, W. M., Dai, H., Chen, P., Li, M., et al. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02701-1 · Cited by 9
Characteristics Associated With Facebook Use and Interest in Digital Disease Support Among Older Adults With Atrial Fibrillation: Cross-Sectional Analysis of Baseline Data From the Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF) Cohort
Waring, M. E., Hills, M. T., Lessard, D., Saczynski, J. S., Libby, B. A., Holovatska, M. M., Kapoor, A., Kiefe, C. I., & McManus, D. D. (2019) · JMIR Cardio · doi:10.2196/15320 · Cited by 9
Impact on a Person’s Daily Life During Episodes of Supraventricular Tachycardia
Nordblom, A.-K., Broström, A., & Fridlund, B. (2016) · Journal of Holistic Nursing · doi:10.1177/0898010116639722 · Cited by 9
Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention
Shahid, F., Shantsila, E., & Lip, G. Y. H. (2016) · F1000Research · doi:10.12688/f1000research.10176.1 · Cited by 10
Preparation for and Implementation of Shared Medical Appointments to Improve Self-Management, Knowledge, and Care Quality Among Patients With Atrial Fibrillation
Griffin, J. M., Stuart-Mullen, L. G., Schmidt, M. M., McCabe, P. J., O'Byrne, T. J., Branda, M. E., & McLeod, C. J. (2018) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2018.06.003 · Cited by 9
Lifestyle interventions after ablation for atrial fibrillation: a systematic review
Larsen, R. T., Gottliebsen, C. R., Wood, K., & Risom, S. S. (2020) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515120919388 · Cited by 10
Validation of the English version of the arrhythmia-specific questionnaire in tachycardia and arrhythmia (ASTA): a Rasch evaluation study
Walfridsson, U., Walfridsson, H., Middeldorp, M. E., Sanders, P., & Årestedt, K. (2022) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-022-00493-4 · Cited by 8
Binding Interaction and Stability Analysis of Quercetin and its Derivatives as Potential Inhibitors of Triple Negative Breast Cancer (TNBC) against PARP1 Protein: An in-silico Study
Hossain, M. A., Fariha, F. M., Hossain, M. A., Kavey, M. R. H., Shamim, M., Hoque, M. M., Hasan, A. M. W., Rahman, M. A., Harrath, A. H., & Rahman, M. H. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128373506250414160220 · Cited by 8
Exploring the Mechanism of Effectiveness of a Psychoeducational Intervention in a Rehabilitation Program (CopenHeartRFA) for Patients Treated With Ablation for Atrial Fibrillation
Risom, S. S., Lind, J., Dickson, V. V., & Berg, S. K. (2019) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000584 · Cited by 7
Patient-reported outcome measures on mental health and psychosocial factors in patients with Brugada syndrome
Six, S., Theuns, P., Libin, P., Nowé, A., Pannone, L., Bogaerts, B., Jaxy, S., Olsen, C., Pappaert, G., Grau, I., et al. (2023) · EP Europace · doi:10.1093/europace/euad205 · Cited by 7
E-health in patients with atrial fibrillation
Hendriks, J., Walfridsson, U., Johansson, P., & Strömberg, A. (2015) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515115616723 · Cited by 7
Older individuals’ need for knowledge and follow‐up about their chronic atrial fibrillation, lifelong medical treatment and medical controls
Lindberg, T., Berglund, J. S., Elmståhl, S., & Bohman, D. (2017) · Scandinavian Journal of Caring Sciences · doi:10.1111/scs.12427 · Cited by 7
The Symptom Checklist: Frequency and Severity Scale – translation and psychometric properties of the Swedish version
Carnlöf, C., Malinowsky, C. W., Insulander, P., Gadler, F., Jensen‐Urstad, M., & Iwarzon, M. (2020) · Nordic journal of nursing research · doi:10.1177/2057158519898383 · Cited by 7
Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization study
Liu, Z., Xie, Q., Xiang, Q., Zhang, H., Mu, G., Zhao, Z., Tao-Tao, H., Wu, T., Wang, N., Zhang, J., et al. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-564 · Cited by 7
Patient concern regarding bleeding side effects from oral anticoagulation therapy for atrial fibrillation: an analysis from the multicentre KiCS-AF registry
Ueda, I., Kohsaka, S., Ikemura, N., Kimura, T., Katsumata, Y., Takemura, R., Suzuki, M., Takatsuki, S., Koide, D., & Fukuda, K. (2023) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvad094 · Cited by 6
Discordant Treatment Goals for Patients With Atrial Fibrillation and Clinical Trials Metrics
Zenger, B., Spertus, J. A., Torre, M., Lyons, A., Bunch, T. J., Hess, R., Zhang, Y., Piccini, J. P., Millar, M. M., Lobban, T., et al. (2024) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2024.06.026 · Cited by 6
Patients perspectives on integrating eHealth in regular care pathways for atrial fibrillation: evaluating photoplethysmography for remote self-assessment
van Mourik, M. J. W., Keijsers, L. C. E. M., van der Velden, R. M. J., Vorstermans, B. J. G. H., Crijns, H. J. G. M., Muris, J. W. M., Linz, D., & Slok, A. H. M. (2025) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvae156 · Cited by 6

Authors: Lane, D. A., Aguinaga, L., Blomström-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M. T., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., Mandrola, J., McCabe, P. J., Pedersen, S. S., Pisters, R., Stewart, S., Wood, K., Potpara, T. S., Reviewers, D., Gorenek, B., Conti, J. B., Keegan, R., Power, S., Hendriks, J., Ritter, P., Calkins, H., Violi, F., & Hurwitz, J.
ORCID: Lane, Deirdre A.
Boriani, Giuseppe
Hills, Mellanie True
Hylek, Elaine M.
Lip, Gregory Y.H.
Mandrola, John
McCabe, Pamela J.
Pedersen, Susanne S.
Pisters, Ron
Stewart, Simon
Wood, Kathryn
Potpara, Tatjana S.
Conti, Jamie Beth
Keegan, Roberto
Hendriks, Jeroen
Ritter, Philippe
Calkins, Hugh
Violi, Francesco
Hurwitz, Jodie
Venue: Europace
Publisher: Oxford University Press (OUP)
Published: 2015-06-24
Volume: 17
Issue: 12
Pages: 1747-1769
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/euv233
OpenAlex: W2153724592
Cited by: 142
References: 240
Citations by year: 2026: 3 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 12 · 2019: 13 · 2018: 20 · 2017: 27 · 2016: 20 · 2015: 7
FWCI: 17.89
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by
Locations: EP Europace (publishedVersion)
Tilburg University Research Portal (publishedVersion)
Research portal (Tilburg University) (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Research Publications (Maastricht University) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
HighWire Press Open Archive (submittedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: cardiac tachyarrhythmias, patient values, patient preferences, shared decision-making, patient experience, medication adherence, patient-centered care, patient advocacy, clinical guidelines
MeSH terms: Arrhythmias, Cardiac, Cardiology, Decision Making, Humans, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Quality of Life, Treatment Outcome, Cost of Illness, Patient-Centered Care, Consensus, Patient Preference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks